Yunkang Group Limited (2325.HK)

11.000 0.000 (0.00%) At close: 04:08PM HKT

Yunkang Group Limited

No. 9 Yayingshi Road
Science City Huangpu District
Guangzhou
China
86 20 3210 6666
https://www.yunkanghealth.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 1,510

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Yong Zhang	Chairman & CEO	292.29k	N/A	1972
Mr. Yingjia Lin	CFO & Joint Company Secretary	N/A	N/A	1980
Mr. Xubo Wang	Executive Vice President	N/A	N/A	1975
Ms. Lok Yee Chan A.C.I.S., A.C.S.	Joint Company Secretary	N/A	N/A	1990

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction and screening tests; and routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. In addition, the company offers diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; healthcare technology development; and project investment. It provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.

Corporate governance

Yunkang Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.